Women who received repeated Depo-Provera shots may need regular MRI and CT scans to watch for the development of brain tumors, medical monitoring lawsuit claims.
Depo-Provera lawsuit claims woman may eventually lose control of her tongue due to a tumor that cannot be surgically removed.
Even after extensive brain surgery, the Depo-Provera brain tumor could return, resulting in a need for yearly MRIs and potential radiation therapy.
Some recipients of the RSV vaccines developed Guillain-Barré syndrome within 42 days of receiving the injection, according to FDA warning.
Growing number of lawsuits against generic Depo-Provera manufacturers allege that women have not been adequately warned about the risk of meningioma brain tumors from the birth control shot.
Lawsuit seeks damages for all users of the recalled sickle cell disease drug, even if they were not physically injured by Oxbryta side effects.
While the manufacturer of the birth control shot agrees that a federal Depo-Provera multidistrict litigation (MDL) should be created, it disagrees with plaintiffs about where the cases should be centralized.
Dozens of women are currently pursuing Depo-Provera brain tumor lawsuits in the federal court system, and it is widely expected that hundreds, if not thousands, of additional claims may be brought in the next year.
Indiana woman must undergo MRI tests every one to two years to monitor the growth of a brain tumor caused by the Depo-Provera shot, according to complaint.
Nearly two dozen Depo-Provera lawsuits have been filed by women nationwide who say they developed brain tumors after receiving the birth control shot.
